Live Price
Live Volume
Ocular Therapeutix Market Segments
Overnight
| Open | $10.53 |
|---|---|
| Close | $10.53 |
| Low | $10.53 |
| Low Change | 0.00 (0.00%) |
| High | $10.53 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 910 |
| Dollar Volume | $9.58K |
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $10.49 |
|---|---|
| Close | $10.69 |
| Low | $10.49 |
| Low Change | 0.00 (0.00%) |
| High | $10.69 |
| High Change | +0.20 (+1.91%) |
| Range | $0.20 |
| Volume | 525.936K |
| Dollar Volume | $5.62M |
Regular Trading Hours Yesterday
| Open | $10.75 |
|---|---|
| Close | $10.50 |
| Low | $10.37 |
| Low Change | -0.39 (-3.58%) |
| High | $10.94 |
| High Change | +0.19 (+1.77%) |
| Range | $0.58 |
| Volume | 1.992M |
| Dollar Volume | $20.91M |
Premarket Yesterday
*No Trades in Segment
Ocular Therapeutix News
1 month agoinvesting.comWhy is Ocular Therapeutix stock rallying today?
- 1 month agoinvesting.com
Ocular Therapeutix stock rises as rival’s wet AMD trial stumbles
- 2 months agoinvesting.com
Ocular Therapeutix options trading jumps to 9,894 contracts
- 6 months agoinvesting.com
EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug
- 6 months agoinvesting.com
EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug
- 7 months agoinvesting.com
Ocular Therapeutix stock news: Why positive data led to a 25% drop
- 7 months agoinvesting.com
Ocular Therapeutix stock tumbles after wet AMD trial results
- 8 months agoinvesting.com
Sanofi readies higher bid for Ocular Therapeutix after initial rejection - report
Ocular Therapeutix Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Ocular Therapeutix Moving Averages
| 5 Day Moving Average (SMA5) | $10.92 |
|---|---|
| 10 Day Moving Average (SMA10) | $10.76 |
| 20 Day Moving Average (SMA20) | $10.82 |
| 50 Day Moving Average (SMA50) | $9.86 |
| 100 Day Moving Average (SMA100) | $9.50 |
| 200 Day Moving Average (SMA200) | $9.93 |
Ocular Therapeutix Statistics
| Average Volume (30 Days) | 2.59M |
|---|---|
| P/E Ratio (Current) | -7.75 |
| EPS (Current) | -$1.37 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$255.10M |
| Cash Ratio | 12.17 |
| Current Ratio | 13.11 |
| Quick Ratio | 13.03 |
| Debt to Equity | 0.14 |
| Enterprise Value | $1.81B |
| EV to EBITDA | -5.86 |
| EV to Sales | 34.70 |
| Price to Book | 4.48 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 44.81 |
| Return on Assets | -0.45% |
| Return on Equity | -0.58% |
Ocular Therapeutix Stock Splits
There have been no stock splits for Ocular Therapeutix (OCUL).
Ocular Therapeutix Dividends
There have been no dividends for Ocular Therapeutix (OCUL).